Get the Stockscreener App
5.9794
1.32%
-0.0706
Reshape Lifesciences Inc stock is traded at $5.9794, with a volume of 29,826.
It is down -1.32% in the last 24 hours and up +19.88% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
See More
Previous Close:
$6.05
Open:
$5.67
24h Volume:
29,826
Relative Volume:
0.16
Market Cap:
$2.98M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0934
EPS:
-64.04
Net Cash Flow:
$-17.45M
1W Performance:
+0.67%
1M Performance:
+19.88%
6M Performance:
-39.20%
1Y Performance:
-59.15%
1-Day Range:
$5.67
$6.09
1-Week Range:
$5.1241
$6.9033
52-Week Range:
$4.60
$34.22
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Reshape Lifesciences Inc Stock (RSLS) Latest News
(RSLS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
What's Driving These Stocks Higher In After-hours? - RTTNews
Objective long/short (RSLS) Report - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Weight-Loss Devices Market 2024: Global Segmentation Trends, - openPR
ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 472.0% in September - MarketBeat
Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech
Gastric Electrical Stimulators Market will attempt to create - openPR
ReShape Lifesciences Enters Into A Merger Agreement With Vyome Therapeutics - MPO-mag
How to Take Advantage of moves in (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
RSLS stock touches 52-week low at $4.99 amid market challenges - Investing.com
Bariatric Surgery Devices Global Market Research 2024-2033: Outlook and Overview - WhaTech
ReShape Lifesciences (OTCMKTS:RSLSD) Trading Up 2.3% - Defense World
Trend Tracker for (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) and Sintx Technologies (NASDAQ:SINT) Head to Head Analysis - Defense World
Gastric Balloon Procedures Market Insights and Growth - openPR
A new trading data show ReShape Lifesciences Inc. (RSLS) is showing positive returns. - SETE News
Dow Rises Over 50 Points; AutoZone Posts Downbeat Earnings - Benzinga
RELX PLC Continues Share Buyback Strategy - TipRanks
The ReShape Lifesciences Inc. (RSLS) had a good session last reading, didn’t it? - US Post News
In the Green: Relay Therapeutics Inc (RLAY) Closes at 7.50, Up/Down -4.58 from Previous Day - The Dwinnex
Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested - Yahoo Finance
REE Automotive Kick-Off U.S. Production With Roush Industries as Contract Manufacturer - StockTitan
Insider’s View: Deciphering ReShape Lifesciences Inc. (RSLS)’s Financial Health Through Ratios - The Dwinnex
ReShape Lifesciences Inc.’s Shares Reel: -42.65% Quarterly Revenue Decline Amid 3.29M Market Cap - The InvestChronicle
Global Neuromodulation Market Innovations Investigated by Share and Outlook 2024 - WhaTech
Respiri Limited Boosts Patient Care with New Agreements - TipRanks
Rubric Capital Management LP Increases Stock Position in ReNew Energy Global Plc (NASDAQ:RNW) - Defense World
ReShape Lifesciences (NASDAQ:RSLS) Shares to Reverse Split on Monday, September 23rd - Defense World
ReShape Lifesciences announces 1-for-58 reverse stock split - Investing.com
ReShape Lifesciences Inc. (RSLS) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
RSLS stock touches 52-week low at $0.14 amid market challenges By Investing.com - Investing.com South Africa
ReShape Lifesciences announces 1-for-58 reverse stock split By Investing.com - Investing.com South Africa
RSLS stock touches 52-week low at $0.14 amid market challenges - Investing.com Canada
Take off with ReShape Lifesciences Inc. (RSLS): Get ready for trading - SETE News
Ratios Reveal: Breaking Down ReShape Lifesciences Inc. (RSLS)’s Financial Health - The Dwinnex
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - GlobeNewswire
Recent Insider Activity Suggests Potential Gains for ReShape Lifesciences Inc. (RSLS) - Knox Daily
The Potential Rise in the Price of Symbotic Inc (SYM) following insiders activity - Knox Daily
These Numbers Prove Just How Vibrant The ASML Holding NV (NASDAQ: ASML) Stock Has Been - Stocks Register
United States Minimally Invasive Bariatric Surgery Device Market By Application - North America Agile Program ...
This Data Shows Just How Strong Catheter Precision Inc. (AMEX: VTAK) Stock Is - Stocks Register
American Airlines Group Inc (AAL) receives a Mkt perform rating from Bernstein - Knox Daily
If You Don’t Buy Mira Pharmaceuticals Inc (NASDAQ: MIRA) Now, You’ll Regret It Later - Stocks Register
Athira Pharma Inc (NASDAQ: ATHA): Slumped -75.09% In 2024, Outlook Stable - Stocks Register
Is Windtree Therapeutics Inc’s (NASDAQ:WINT) Stock On The Decline? - Stocks Register
Faraday Future Intelligent Electric Inc’s (NASDAQ: FFIE) Stock Price Continues To Fall - Stocks Register
How to interpret ReShape Lifesciences Inc. (RSLS)’s stock chart patterns - US Post News
Are Value Hunters Buying Bionano Genomics Inc (NASDAQ: BNGO) Stock? - Stocks Register
Would I Buy Public Service Enterprise Group Inc. (NYSE: PEG) Stock At Any Time In The Future? - Stocks Register
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):